| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/17/2003 | CA2471957A1 Cyclic tetrapeptide compound and use thereof |
| 07/17/2003 | CA2471951A1 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2471657A1 Methods for improving the aesthetic appearance of skin |
| 07/17/2003 | CA2471504A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | CA2471490A1 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 07/17/2003 | CA2471432A1 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | CA2470389A1 Use of cytokines secreted by dendritic cells |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
| 07/17/2003 | CA2463798A1 Modulation of immunostimulatory propertiies of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/16/2003 | EP1327451A1 Adjuvants for vaccines |
| 07/16/2003 | EP1327449A1 Remedies for ischemic diseases |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |
| 07/16/2003 | EP1326972A2 Transporters and ion channels |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326961A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 07/16/2003 | EP1326960A2 Microbes having an attenuating mutation comprising a transcription terminator |
| 07/16/2003 | EP1326896A2 Human anti-cd40 antibodies |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326869A1 Pyrrole-condensed morphinoid derivatives |
| 07/16/2003 | EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326863A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 07/16/2003 | EP1326859A1 Quinazoline derivatives with anti-tumour activity |
| 07/16/2003 | EP1326858A2 Piperidine compounds as anti-allergic |
| 07/16/2003 | EP1326857A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonists |
| 07/16/2003 | EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 07/16/2003 | EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 07/16/2003 | EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 07/16/2003 | EP1326843A1 Pyrazole derivatives for the treatment of viral diseases |
| 07/16/2003 | EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 07/16/2003 | EP1326645A1 Complexes for transferring nucleic acids into cells |
| 07/16/2003 | EP1326642A2 Catecholamine pharmaceutical compositions and methods |
| 07/16/2003 | EP1326639A1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 07/16/2003 | EP1326638A2 Vaccines |
| 07/16/2003 | EP1326637A2 Vaccine comprising heat stress proteins from herbaceous plants |
| 07/16/2003 | EP1326634A1 Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 07/16/2003 | EP1326633A1 Composition comprising immunogenic microparticles |
| 07/16/2003 | EP1326630A2 Use of glp-1 and glp-2 peptides |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326611A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1326603A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 07/16/2003 | EP1326589A2 Nanoparticles |
| 07/16/2003 | EP1326586A1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 07/16/2003 | EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 07/16/2003 | EP1109789B1 Triptolide prodrugs having high aqueous solubility |
| 07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/16/2003 | EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 07/16/2003 | EP0758328B1 Anti-cancer compounds containing cyclopentaquinazoline ring |
| 07/16/2003 | EP0743856B1 Antigen-based heteropolymers for treating autoimmune diseases |
| 07/16/2003 | CN1430728A Modulation of T-cell receptor interactions |
| 07/16/2003 | CN1430626A Sheep lice Bobicola ovis allergen treatment |
| 07/16/2003 | CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 07/16/2003 | CN1430620A Macrolides compound |
| 07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
| 07/16/2003 | CN1430521A Solid dispersion system of Pranlukast with improved dissolution, and the preparing method thereof |
| 07/16/2003 | CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/16/2003 | CN1429834A Fructus gleditsiae total saponin, its preparation method and use in preparation of medicine |
| 07/16/2003 | CN1429622A Radix rhodiolae double action lozenge |
| 07/16/2003 | CN1429558A Mannosan peptide injection and its preparation and use method |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114591C Cyclic amide compounds |
| 07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
| 07/15/2003 | US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases |
| 07/15/2003 | US6593343 Antiinflammatory agents; autoimmune diseases |
| 07/15/2003 | US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6593133 Neurotrophic factors |
| 07/15/2003 | US6592907 Treating an eye infections; cleansing a contact lens in place on an eye |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/15/2003 | US6592877 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | CA2238465C Triaromatic compounds, compositions containing them and uses |
| 07/15/2003 | CA2218766C Bicyclic-aromatic compounds |
| 07/15/2003 | CA2086221C Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent |
| 07/15/2003 | CA2067408C 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors |
| 07/10/2003 | WO2003056012A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | WO2003055993A1 Composition of antibody specifically binding to cd20 |
| 07/10/2003 | WO2003055989A2 Cellular compositions and methods of making and using them |
| 07/10/2003 | WO2003055980A2 Il-17 like molecules and uses thereof |
| 07/10/2003 | WO2003055916A2 Adiponectin fragments and conjugates |
| 07/10/2003 | WO2003055915A2 Human netrin receptor and uses thereof |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |
| 07/10/2003 | WO2003055911A2 Cystine-knot fold protein |